( University of Colorado Denver ) Scientists from the University of Colorado Cancer Center have once again advanced the treatment of a specific kind of lung cancer. The team has documented how anaplastic lymphoma kinase positive advanced non-small cell lung cancer becomes resistant to a drug targeting the abnormal protein in the cancer. It's the first time scientists have analyzed the frequency ...